Pediatrics

Young children using a hybrid closed-loop insulin delivery system spent 12% more time within their target blood glucose range than those who received standard care, according to new research.

The FDA authorized Pfizer's bivalent vaccine as a booster dose for children aged under 5 years who received 3 doses of monovalent vaccine.

Youth at the upper range of normal weight had a 26% higher risk of developing hypertension than those in the lower range of normal weight, according to a new study.

The SGLT-2 inhibitor, if approved for this age group, would be the first agent in the class with the indication as adjunctive treatment for T2D for those younger than age 18.

About 60% of dual vapers experienced depression and 52% experienced anxiety, according to findings from a survey of over 2500 youth and young adults.

Substance use among teenagers decreased for some substances from 2011 to 2021, but there is still progress to be made, according to the latest CDC Youth Risk Behavior Survey.

Your daily dose of clinical news you may have missed.

Find key takeaways from the US Centers for Disease Control and Prevention's latest Youth Risk Behavior Survey in our new slideshow.

Future studies may consider PARS the new gold standard in predicting pediatric asthma risk, said study authors.

Pfizer will present pivotal phase 3 data for RSVpreF to the ACIP on February 23; FDA has set a PDUFA date for the vaccine candidate of August 2023.

Your daily dose of clinical news you may have missed.

Reductions in depressive symptoms were greater in adolescents aged ≥13 years and in those with a mental illness and/or depression diagnosis, according to systematic review and meta-analysis.

The novel oral agent is administered once daily for 14 days and has demonstrated rapid and sustained improvement in symptoms across trials.

Vaccination was associated with lower risks of infection, COVID-19-related illnesses, and hospitalizations due to COVID-19-related illnesses in children.

The COVID-19 pandemic derailed routine immunizations and triggered a flood of vaccine misinformation beyond the COVID shot. Here, 3 ways to move forward.

AAFP president Tochi Iroku-Malize, MD, MPH, MBA, urges gentle but persistent efforts among all clinicians to get school-aged children back on vaccination track.

Tochi Iroku-Malize, MD, MPH, MBA, converts the 93% immunization rate for US kindergarteners into raw numbers of children now vulnerable to vaccine-preventable disease.

Your daily dose of clinical news you may have missed.

An overall good quality of diet and higher fish intake during pregnancy were related to better language skills in 2-year-old children, according to new study.

Ingestion of cannabis is now the cause of 1 in every 3 pediatric poisoning hospitalizations in Canadian provinces where edibles are sold legally.

Your daily dose of clinical news you may have missed.

The 13 Key Action Steps in the AAP's landmark obesity guidelines reflect more than a decade of research on evaluation and treatment of the disease in children and adolescents.

Findings suggest that school-based gardening, nutrition, and cooking interventions may improve metabolic parameters in high-risk children.

Diabetes cases in the US among those younger than age 20 years, if left unchecked, are projected to increase by more than 600% by 2060, according to new projections.

Adolescents with more positive psychological assets were more likely to have good cardiometabolic health 2 decades later, and associations were stronger for Black youth.

If approved, nirsevimab would be the first single-dose RSV preventative option for the broad newborn and infant population in the US.

The comprehensive recommendations are the first in 15 years and focus on early evaluation and aggressive treatment that includes family support and accommodates social determinants of health.

Your daily dose of clinical news you may have missed.

Findings highlight the need for extended efforts directed to prevent childhood obesity, especially targeting lower socioeconomic areas, say study authors.

A new study points to the Pfizer shot's initially limited protection against the COVID-19 Omicron variant in those aged 5-11 years and also the the value of vaccine boosters.